tirofiban has been researched along with Blood Clot in 83 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (7.23) | 18.2507 |
| 2000's | 36 (43.37) | 29.6817 |
| 2010's | 27 (32.53) | 24.3611 |
| 2020's | 14 (16.87) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, Z; Cao, C; Ding, X; Feng, S; Kong, Y; Li, H; Li, Y; Li, Z; Oscar, B; Pan, C; Wang, W; Xie, Z; Zhao, L | 1 |
| Javed, M; Rahman, MN | 1 |
| Esposito, G; Ettori, F; Ferlini, M; Lettieri, C; Marchese, A; Musumeci, G; Passamonti, E; Pierini, S; Rigattieri, S; Romano, M; Tarantini, G; Testa, L; Tiberti, G | 1 |
| Chilbert, MR; Denny, O; Mills, K; Woodruff, AE | 1 |
| Emani, SM; Piekarski, BL; Rogers, J; Thiagarajan, R; Zurakowski, D | 1 |
| Wang, J; Xu, X | 1 |
| Gao, C; Han, X; Mitchell, MJ; Nie, G; Wang, C; Wang, K; Xu, J; Yan, N; Yang, C; Zhang, Y | 1 |
| Aguilar-Pérez, M; Ainz-Gómez, L; Amaya Pascasio, L; Baena-Palomino, P; Bravo Rey, I; Cabezas-Rodríguez, JA; Castellanos Rodrigo, MDM; de Albóniga-Chindurza, A; Delgado-Acosta, F; Díaz Pérez, J; Escudero-Martínez, I; Fernandez Prudencio, L; Freijo Guerrero, MDM; Gamero-García, MÁ; González Díaz, E; González García, A; Hidalgo, C; Jiménez Jorge, S; Jiménez-Gómez, E; Medina-Rodríguez, M; Moniche, F; Montaner, J; Morales Caba, L; Mosteiro, S; Ortega-Quintanilla, J; Oteros Fernández, R; Pardo-Galiana, B; Ramirez Moreno, JM; Rosso Fernández, C; Sanz-Fernandez, G; Vielba-Gomez, I; Zamora, A; Zapata-Arriaza, E | 1 |
| Adair, BD; Ahn, HS; Alonso, JL; Arnaout, MA; Hayes, V; Lin, SW; Poncz, M; van Agthoven, J; Xiong, JP; Yu, IS | 1 |
| Chung, J; Lee, D; Lee, DH; Park, JC; Sheen, JJ; Shin, JH; Song, Y; Suh, DC | 1 |
| Nei, SD; Orzel, LA; Ritchie, BM; Stulak, JM; Wieruszewski, PM | 1 |
| Bärnthaler, T; Buschmann, E; Heinemann, A; Mahla, E; Prüller, F; Schuligoi, R; Toth, GG | 1 |
| Abu-Fares, O; Behme, D; Clajus, C; Ernst, M; Fiorella, D; Götz, FG; Klisch, J; Lobsien, D; Riedel, CH | 1 |
| Chen, Y; Wang, B; Wang, W; Wei, S | 1 |
| Çavuşoğlu, Y; Iskenderov, K; Mutlu, F; Şenol, U; Tahmazov, S; Ulus, T | 1 |
| Gwon, S; Hwang, DW; Jeon, J; Kang, C; Kang, PM; Lee, D; Park, SC; Song, C | 1 |
| Choudhary, MI; Moin, SF; Waheed, H | 1 |
| Chourdakis, E; Hahalis, G; Koniari, I; Kounis, NG; Patsouras, N; Roumeliotis, A; Soufras, G; Tsigkas, G | 1 |
| Li, J; Li, W; Wu, W; Xie, Q; Zhang, W; Zhang, Y; Zhang, Z | 1 |
| Huo, X; Miao, Z; Wang, Y; Yang, M | 1 |
| Gao, YX; Li, L; Li, Y; Sun, TW; Yu, XZ; Yuan, YQ; Zhao, XY | 1 |
| Austin, D; Christie, J; de Belder, MA; Hennigan, B; Mackay, DF; Morley, R; Oldroyd, KG; Pell, JP | 1 |
| Natarajan, D | 1 |
| Heemskerk, JW; Lancé, MD; Lionikiene, AS; Mastenbroek, TG; Mutch, NJ; Swieringa, F; van der Meijden, PE; Whyte, CS | 1 |
| Harmon, C; King, S; Short, M | 1 |
| Ahn, JH; Chang, IB; Jun, HS; Kim, JH; Oh, JK; Song, JH | 1 |
| Dreysse, S; Falk, V; Kaufmann, F; Krabatsch, T; Kretzschmar, A; Müller, M; Pergantis, P; Pieri, M; Potapov, EV; Scandroglio, AM | 1 |
| Bansilal, S; Becker, RC; Cannon, CP; Harrington, RA; Himmelmann, A; Husted, S; James, SK; Katus, HA; Lopes, RD; Neely, B; Shimada, YJ; Steg, PG; Storey, RF; Wallentin, L; Wiviott, SD | 1 |
| Cao, Z; Gao, L; Zhang, H | 1 |
| Cao, Y; Ding, X; Gamariel, RR; Kong, Y; Li, ZY; Liu, TD; Liu, XD; Ming, X; Wang, CH; Xie, ZL; Zhao, Q | 1 |
| Dembo, L; Lovett, M; O'Driscoll, G; Thomas, MD; Wood, C | 1 |
| Beiras-Fernandez, A; Jiru, P; Kowert, A; Reichart, B; Schmoeckel, M; Spannagl, M; Weis, M | 1 |
| Chiariello, M; D'andrea, C; Esposito, G; Piscione, F | 1 |
| Beresford-Cleary, NJ; Chelliah, R; Connolly, TM; Cortas, K; Daga, S; Feuerstein, GZ; Fox, KA; Lucking, AJ; Newby, DE; Tattersall, L | 1 |
| Bates, ER; Chetcuti, S; Grossman, PM; Gurm, HS; Meier, P; Tamhane, U | 1 |
| Dai, K; Li, S; Liu, G; Shi, Q; Wang, Y; Wang, Z; Zhang, W | 1 |
| Lin, X; Liu, Y; Ni, Z; Wan, X; Yang, X; Zhang, L; Zhang, Z | 1 |
| Anselmi, M; Bolognese, L; Bressers, M; Bristot, L; Campo, G; Colangelo, S; De Cesare, N; Gambetti, S; Garcia-Garcia, HM; Garg, S; Monti, M; Moreno, R; Parrinello, G; Rodriguez, AE; Sarno, G; Serruys, PW; Valgimigli, M | 1 |
| Dziegielewski, P; Fu Zhu, L; Harris, J; Seikaly, H; Singh, P | 1 |
| Cheng, CF; Cheng, WT; Kikuchi, T; Lian, WS; Lin, H | 1 |
| Schneider, DJ | 1 |
| Badenhorst, PN; Lamprecht, S; Meiring, SM; Roodt, JP; van Rensburg, WJ | 1 |
| De Caterina, R; Grove, EL; Huber, K; Kristensen, SD; Moliterno, DJ; Neumann, FJ; Würtz, M | 1 |
| Aksakal, E; Inci, S; Karakelleoğlu, S; Sevimli, S | 1 |
| Davutoglu, V; Ercan, S; Ozer, O; Sari, I; Yuce, M | 1 |
| Bellandi, F; Cutlip, D; De Luca, G; Dudek, D; Emre, A; Gabriel, HM; Gibson, CM; Gyongyosi, M; Huber, K; Maioli, M; Noc, M; Rakowski, T; Secco, GG; van 't Hof, AW; Zeymer, U; Zorman, S | 1 |
| Ambrosini, V; Battaglia, S; Cioppa, A; Lo Muzio, L; Rubino, P; Salemme, L; Sorropago, G; Tesoria, T | 1 |
| Azarbal, B; Cercek, B; Finkelstein, A; Kaul, S; Rukshin, V; Shah, PK; Tsang, V | 1 |
| Harrington, RA; Nguyen, CM | 1 |
| Dai, W; Kloner, RA | 1 |
| Goto, S; Ishida, H; Tamura, N | 1 |
| Allie, AA; Allie, DE; Allie, SD; Chaisson, GA; Fail, PS; Hebert, CJ; Keller, VA; Khan, MA; Khan, MH; Lirtzman, MD; Mitran, EV; Stagg, SJ; Vitrella, DA; Walker, CM; Wyatt, CH | 1 |
| Eberli, FR; Hess, OM; Locher, S; Meier, B; Remondino, A; Rey, C; Seiler, C; Togni, M; Tüller, D; Wenaweser, P; Windecker, S | 1 |
| Cohen, EA; Fort, S; Godin-Edgecombe, M; Madan, M; Naqvi, SZ; Paradiso-Hardy, FL; Phillips, AM; Radhakrishnan, S; Reis, M; Shanmugasegaram, S; Sparling, C | 1 |
| Concannon, MJ; Farias, CL; Kazmier, FR; Puckett, CL; Yates, YJ | 1 |
| Biscione, C; Crea, F; De Vita, M; Maria Leone, A; Mongiardo, R; Niccoli, G; Rebuzzi, A | 1 |
| Cardaioli, P; Giordan, M; Magro, B; Maronati, L; Rigatelli, G; Roncon, L; Zonzin, P | 1 |
| Goto, S; Ishida, H; Ruggeri, ZM; Tamura, N | 1 |
| Ahrens, I; Bassler, N; Bode, C; Chen, YC; Fitzgerald, D; Hagemeyer, CE; Kenny, D; Meade, G; Moran, N; Peter, K; Schwarz, M; Stoll, P; Ylanne, J | 1 |
| Burns, G; Meola, S; Mohammad, S; Solen, K; Sukavaneshvar, S | 1 |
| Fontana, P | 1 |
| Chung, TL; Holton, LH; Pumplin, DW; Rodriguez, ED; Silverman, RP; Taylor, JA | 1 |
| Bittmann, I; Brandl, U; Brenner, P; Burdorf, L; Erhardt, M; Hammer, C; Jöckle, H; Michel, S; Mordstein, V; Reichart, B; Rössle, M; Schmoeckel, M; Thein, E | 1 |
| Kim, DJ; Lee, KO; Lee, KY; Seo, KD | 1 |
| Allegretto, N; Barbera, F; Bird, JE; Giancarli, MR; Ogletree, ML; Schumacher, WA; Seiffert, D; Wong, P | 1 |
| Cook, JJ; Holahan, MA; Lynch, JJ; Lynch, RJ; Mellott, MJ; Ramjit, DR; Sitko, GR; Stabilito, II; Stranieri, MT; Zhang, G | 1 |
| Anderson, KM; Coller, BS; Weisman, HF | 1 |
| Kleiman, NS | 1 |
| Edmunds, LH; Gorman, JH; Hiramatsu, Y; Rao, AK; Sun, L | 1 |
| Dunn, A | 1 |
| Atar, S; Birnbaum, Y; Luo, H; Nagai, T; Siegel, RJ | 1 |
| Ali, A; Grady, KJ; Patil, S; Schreiber, TL | 1 |
| Mohammad, SF; Solen, KA; Sukavaneshvar, S | 1 |
| Collinson, J; Flather, M; Gomma, A; Purcell, H | 1 |
| Eto, K; Goto, S; Handa, S; Ichikawa, N; Isshiki, T; Kim, JY; Nagaoka, Y; Sakakibara, M; Shimazaki, T; Yoshida, M | 1 |
| Bassand, JP | 1 |
| Vernon, SM | 1 |
| Böck, K; Calais, P; Herrlinger, JD; Schommer, B; Schröder, J | 1 |
| Corno, A; Horisberger, J; Marty, B; Mueller, X; von Segesser, LK | 1 |
| Aulich, A; Junghans, U; Seitz, RJ; Siebler, M; Wittsack, HJ | 1 |
| Galli, M | 1 |
| Cercek, B; Finkelstein, A; Kaul, S; Rukshin, V; Shah, PK; Tsang, V | 1 |
| Henry, RG; Little, JW; McIntosh, BA; Miller, CS | 1 |
15 review(s) available for tirofiban and Blood Clot
| Article | Year |
|---|---|
Anti-Platelet Peptides Targeting αIIbβ3 Outside-In Signaling Pathway.
Topics: Abciximab; Eptifibatide; Humans; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Signal Transduction; Thrombosis; Tirofiban | 2023 |
Snake Venom: From Deadly Toxins to Life-saving Therapeutics.
Topics: Animals; Anticoagulants; Batroxobin; Blood Coagulation; Captopril; Peptides; Snake Venoms; Snakes; Thrombosis; Tirofiban; Toxins, Biological; Tyrosine | 2017 |
Platelet Glycoprotein IIb/IIIa Receptor Inhibitor Tirofiban in Acute Ischemic Stroke.
Topics: Brain Ischemia; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Stroke Rehabilitation; Thrombosis; Tirofiban | 2019 |
Glycoprotein IIb/IIIa inhibitors: The resurgence of tirofiban.
Topics: Abciximab; Acute Coronary Syndrome; Antibodies, Monoclonal; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Thrombosis; Tirofiban; Tyrosine | 2016 |
A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Eptifibatide; Female; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recurrence; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2009 |
Current issues with glycoprotein IIb-IIIa antagonists.
Topics: Abciximab; Acute Coronary Syndrome; Antibodies, Monoclonal; Anticoagulants; Eptifibatide; Hemostasis; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine | 2011 |
Contemporary use of glycoprotein IIb/IIIa inhibitors.
Topics: Abciximab; Acute Coronary Syndrome; Angioplasty; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Thrombosis; Tirofiban; Tyrosine | 2012 |
Glycoprotein IIb/IIIa receptor antagonists: a comparative review of their use in percutaneous coronary intervention.
Topics: Abciximab; Angioplasty; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Restenosis; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Thrombosis; Tirofiban; Tyrosine | 2003 |
[Update on antithrombotic treatments in arterial diseases].
Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Arteriosclerosis; Aspirin; Dipyridamole; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Pyridines; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine | 2007 |
The anti-GPIIb-IIIa agents: fundamental and clinical aspects.
Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Drug Evaluation, Preclinical; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Mice; Multicenter Studies as Topic; Oligopeptides; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Fusion Proteins; Thrombosis; Tirofiban; Tyrosine | 1996 |
Pharmacology of the intravenous platelet receptor glycoprotein IIb-IIIa antagonists.
Topics: Abciximab; Acetates; Antibodies, Monoclonal; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine | 1998 |
Low-molecular-weight heparin and other antithrombotic agents in the setting of a fast-track revascularization in unstable coronary artery disease.
Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clinical Trials as Topic; Combined Modality Therapy; Diabetes Complications; Drug Therapy, Combination; Eptifibatide; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Hirudin Therapy; Hirudins; Humans; Immunoglobulin Fab Fragments; Myocardial Revascularization; Oligosaccharides; Peptide Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Randomized Controlled Trials as Topic; Recombinant Proteins; Risk Factors; Thrombocytopenia; Thrombosis; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2000 |
Glycoprotein IIb/IIIa antagonists and low-molecular weight heparin in acute coronary syndromes.
Topics: Abciximab; Angina, Unstable; Antibodies, Monoclonal; Coronary Artery Bypass; Dalteparin; Enoxaparin; Eptifibatide; Fibrinolytic Agents; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Nadroparin; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Thrombosis; Tirofiban; Transaminases; Tyrosine | 2001 |
Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass.
Topics: Abciximab; Ancrod; Antibodies, Monoclonal; Anticoagulants; Arginine; Cardiopulmonary Bypass; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Drug Combinations; Drug Hypersensitivity; Factor Xa Inhibitors; Hemodilution; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Humans; Immunoglobulin Fab Fragments; Perfusion; Pipecolic Acids; Platelet Aggregation Inhibitors; Protamines; Sulfonamides; Thrombocytopenia; Thrombophilia; Thrombosis; Tirofiban; Tyrosine | 2001 |
Antithrombotic agents: implications in dentistry.
Topics: Anticoagulants; Aspirin; Blood Coagulation Tests; Clopidogrel; Dental Care; Drug Interactions; Embolism; Fibrinolytic Agents; Hemostasis; Heparin; Heparin, Low-Molecular-Weight; Humans; Oral Hemorrhage; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Ticlopidine; Tirofiban; Tyrosine; Venous Thrombosis; Warfarin | 2002 |
6 trial(s) available for tirofiban and Blood Clot
| Article | Year |
|---|---|
Safety and efficacy of tirofiban in acute ischemic stroke due to tandem lesions undergoing mechanical thrombectomy: A multicenter randomized clinical trial (ATILA) protocol.
Topics: Aspirin; Brain Ischemia; Clinical Trials, Phase IV as Topic; Humans; Ischemic Stroke; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; Thrombectomy; Thrombosis; Tirofiban; Treatment Outcome | 2023 |
Myocardial reperfusion with tirofiban injection via aspiration catheter : Efficacy and safety in STEMI patients with large thrombus burden.
Topics: Angioplasty, Balloon, Coronary; Fibrinolytic Agents; Humans; Myocardial Reperfusion; Percutaneous Coronary Intervention; ST Elevation Myocardial Infarction; Thrombosis; Tirofiban; Treatment Outcome | 2020 |
[Prevention of non-acute stent thrombosis after drug-eluting stent implantation].
Topics: Aspirin; Clopidogrel; Drug-Eluting Stents; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Tirofiban; Tyrosine; Warfarin | 2013 |
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
Topics: Abciximab; Acute Coronary Syndrome; Adenosine; Aged; Antibodies, Monoclonal; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Eptifibatide; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2Y Receptor Antagonists; Stroke; Thrombosis; Ticagrelor; Ticlopidine; Tirofiban; Tyrosine | 2016 |
Efficacy and Safety of Thrombectomy Combined with Intracoronary Administration of Tirofiban in ST-segment Elevation Myocardial Infarction (STEMI).
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Combined Modality Therapy; Coronary Angiography; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Thrombectomy; Thrombosis; Tirofiban; Tyrosine | 2016 |
Comparison of enoxaparin versus heparin during elective percutaneous coronary intervention performed with either eptifibatide or tirofiban (the ACTION Trial).
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Drug Therapy, Combination; Elective Surgical Procedures; Enoxaparin; Eptifibatide; Female; Fibrinolytic Agents; Heparin; Humans; Integrin alpha2; Integrin beta3; Male; Membrane Glycoproteins; Middle Aged; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine | 2005 |
62 other study(ies) available for tirofiban and Blood Clot
| Article | Year |
|---|---|
Design, synthesis and evaluation of novel 2-amino-3-(naphth-2-yl)propanoic acid derivatives as potent inhibitors of platelet aggregation.
Topics: Drug Design; Hemorrhage; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Propionates; Thrombosis | 2017 |
Tirofiban and Rivaroxaban use in the management of right coronary artery thrombus as a primary manifestation of essential thrombocythemia.
Topics: Coronary Vessels; Drug-Eluting Stents; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Rivaroxaban; Thrombocythemia, Essential; Thrombosis; Tirofiban | 2022 |
Primary Percutaneous Coronary Intervention with High-Bolus Dose Tirofiban: The FASTER (Favorite Approach to Safe and Effective Treatment for Early Reperfusion) Multicenter Registry.
Topics: Aged; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Registries; Reperfusion; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine | 2022 |
Comparison of Ischemic and Bleeding Events Between Short-Duration Versus Long-Duration Tirofiban Regimens in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Topics: Clopidogrel; Hemorrhage; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Retrospective Studies; ST Elevation Myocardial Infarction; Thrombosis; Ticagrelor; Tirofiban; Treatment Outcome | 2022 |
Exploratory Use of Glycoprotein IIb/IIIa Inhibition in Prevention of Blalock-Taussig Shunt Thrombosis.
Topics: Anticoagulants; Aspirin; Blalock-Taussig Procedure; Cohort Studies; Fibrinolytic Agents; Hemorrhage; Humans; Integrin alpha2; Integrin beta3; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Thrombosis; Tirofiban; Treatment Outcome | 2022 |
Platelet-Mimicking Nanosponges for Functional Reversal of Antiplatelet Agents.
Topics: Animals; Blood Platelets; Hemorrhage; Mice; Platelet Aggregation Inhibitors; Thrombosis; Ticagrelor; Tirofiban | 2023 |
Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis.
Topics: Animals; Blood Coagulation; Disease Models, Animal; Drug Design; Gene Knock-In Techniques; Healthy Volunteers; Hemorrhage; Humans; K562 Cells; Male; Mice; Mice, Transgenic; Peptides; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Structure-Activity Relationship; Thrombosis; Tirofiban; von Willebrand Factor | 2020 |
Timing of Thrombosis in Embolization of Unruptured Intracranial Aneurysms : Tirofiban as Rescue Treatment.
Topics: Aneurysm, Ruptured; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Retrospective Studies; Stents; Thrombosis; Tirofiban; Treatment Outcome | 2021 |
Tirofiban in Suspected Left Ventricular Assist Device Pump Thrombosis.
Topics: Cohort Studies; Female; Heart-Assist Devices; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Thrombosis; Tirofiban | 2020 |
Supplemental Fibrinogen Restores Platelet Inhibitor-Induced Reduction in Thrombus Formation without Altering Platelet Function: An In Vitro Study.
Topics: Aged; Aspirin; Calcium Signaling; Female; Fibrinogen; Hemorheology; Heparin; Hirudins; Humans; In Vitro Techniques; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Thrombosis; Ticagrelor; Tirofiban | 2020 |
Aneurysm Treatment in Acute SAH with Hydrophilic-Coated Flow Diverters under Single-Antiplatelet Therapy: A 3-Center Experience.
Topics: Aged; Aneurysm, Ruptured; Embolization, Therapeutic; Endovascular Procedures; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Subarachnoid Hemorrhage; Thrombosis; Tirofiban; Treatment Outcome | 2021 |
Late Stent Thrombosis After Drug-Coated Balloon Coronary Angioplasty for In-Stent Restenosis.
Topics: Acute Disease; Adult; Aftercare; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Occlusion; Coronary Restenosis; Cytochrome P-450 CYP2C19; Dual Anti-Platelet Therapy; Female; Fibrinolytic Agents; Humans; Integrin alpha2; Mutation; Myocardial Infarction; Purinergic P2Y Receptor Antagonists; Stents; Thrombectomy; Thrombosis; Ticagrelor; Tirofiban; Treatment Outcome | 2021 |
High-dose bolus tirofiban versus low-dose bolus in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Postoperative Complications; Retrospective Studies; Thrombosis; Tirofiban; Tyrosine | 2017 |
Fibrin-Targeted and H
Topics: Animals; Boronic Acids; Carotid Artery Thrombosis; CD40 Ligand; Cell Survival; Chlorides; Drug Carriers; Drug Liberation; Endothelial Cells; Ferric Compounds; Fibrin; Fibrinolytic Agents; Fluorescent Dyes; Humans; Hydrogen Peroxide; Lipopeptides; Mice; Nanoparticles; Optical Imaging; Polymers; RAW 264.7 Cells; Theranostic Nanomedicine; Thrombosis; Tirofiban; Tumor Necrosis Factor-alpha | 2017 |
Perioperative Management of Dual Antiplatelet Therapy.
Topics: Aspirin; Elective Surgical Procedures; Hemorrhage; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Tirofiban; Tyrosine | 2018 |
High-bolus dose tirofiban compared with abciximab in primary percutaneous coronary intervention: a propensity score-matched outcome study.
Topics: Abciximab; Aged; Antibodies, Monoclonal; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Propensity Score; Survival Analysis; Thrombocytopenia; Thrombosis; Tirofiban; Tyrosine | 2015 |
Acute thrombosis during left main stenting using tap technique in a patient presenting with non-ST-segment elevation acute coronary syndrome.
Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Drug Combinations; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine | 2015 |
Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow.
Topics: Blood Platelets; Crotalid Venoms; Fibrin; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Flow Cytometry; Hemostatics; Hirudins; Lectins, C-Type; Microscopy, Confocal; Oligopeptides; Phosphatidylserines; Protein Binding; Rheology; Shear Strength; Thrombin; Thrombosis; Tirofiban; Tissue Plasminogen Activator; Tyrosine; Urokinase-Type Plasminogen Activator | 2015 |
Thrombus remnant despite intra-arterial thrombolysis for thrombus formation during endovascular treatment of ruptured cerebral aneurysms: Does it harm?
Topics: Adult; Aged; Aged, 80 and over; Aneurysm, Ruptured; Cerebral Angiography; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Intracranial Aneurysm; Male; Middle Aged; Stents; Thrombolytic Therapy; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine | 2016 |
Diagnosis and Treatment Algorithm for Blood Flow Obstructions in Patients With Left Ventricular Assist Device.
Topics: Algorithms; Equipment Design; Equipment Failure; Female; Fibrinolytic Agents; Heart-Assist Devices; Humans; Male; Middle Aged; Retrospective Studies; Thrombectomy; Thrombosis; Tirofiban; Tyrosine | 2016 |
A Naphthalenic Derivative ND-1 Inhibits Thrombus Formation by Interfering the Binding of Fibrinogen to Integrin
Topics: Abciximab; Animals; Antibodies, Monoclonal; Cardiovascular Diseases; Disease Models, Animal; Eptifibatide; Fibrinogen; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Integrin alpha2; Integrin beta3; Mice; Naphthalenes; Peptides; Platelet Aggregation; Rats; Thrombocytopenia; Thrombosis; Tirofiban; Tyrosine | 2016 |
Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban.
Topics: Adult; Anticoagulants; Aspirin; Female; Heart-Assist Devices; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine; Warfarin | 2008 |
Acute profound thrombocytopenia after treatment with tirofiban and off-pump coronary artery bypass grafting.
Topics: Acute Coronary Syndrome; Acute Disease; Angina, Unstable; Coronary Angiography; Coronary Artery Bypass, Off-Pump; Follow-Up Studies; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Platelet Transfusion; Postoperative Complications; Preoperative Care; Risk Assessment; Severity of Illness Index; Thrombocytopenia; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine | 2009 |
Tirofiban administration and percutaneous coronary intervention with stenting of saphenous vein graft thrombosis.
Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Constriction, Pathologic; Coronary Angiography; Coronary Artery Bypass; Drug Administration Schedule; Embolism; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Male; Saphenous Vein; Stents; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine | 2009 |
P-selectin antagonism reduces thrombus formation in humans.
Topics: Adolescent; Adult; Blood; Cells, Cultured; Cross-Over Studies; Double-Blind Method; Humans; Hydroxyquinolines; P-Selectin; Perfusion; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine; Young Adult | 2009 |
Mechanism of platelet functional changes and effects of anti-platelet agents on in vivo hemostasis under different gravity conditions.
Topics: Actin Cytoskeleton; Adenosine Diphosphate; Animals; Aspirin; Blood Platelets; Calcium; Chelating Agents; Contractile Proteins; Egtazic Acid; Filamins; Hemostasis; Humans; Hypergravity; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microfilament Proteins; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Protein Binding; Ristocetin; Thrombosis; Time Factors; Tirofiban; Tyrosine; Weightlessness Simulation | 2010 |
Non-ST-segment elevation myocardial infarction in a patient with essential thrombocythemia treated with glycoprotein IIb/IIIa inhibitor: a case report.
Topics: Electrocardiography; Enzyme Inhibitors; Humans; Hydroxyurea; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Thrombosis; Tirofiban; Tyrosine | 2011 |
Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolim
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Cardiovascular Agents; Coronary Angiography; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Immunoglobulin Fab Fragments; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; ROC Curve; Severity of Illness Index; Sirolimus; Stents; Thrombosis; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2011 |
Heparin versus tirofiban in microvascular anastomosis: randomized controlled trial in a rat model.
Topics: Anastomosis, Surgical; Animals; Disease Models, Animal; Drug Therapy, Combination; Fascia; Fibrinolytic Agents; Follow-Up Studies; Free Tissue Flaps; Head and Neck Neoplasms; Heparin; Microsurgery; Neoplasms, Experimental; Plastic Surgery Procedures; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Rats; Rats, Sprague-Dawley; Skin Transplantation; Therapeutic Irrigation; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine; Wound Healing | 2011 |
Granulocyte-CSF induced inflammation-associated cardiac thrombosis in iron loading mouse heart and can be attenuated by statin therapy.
Topics: Animals; Disease Models, Animal; Endothelial Cells; Fibrosis; Granulocyte Colony-Stimulating Factor; Heart Ventricles; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Macrophages; Male; Mice; Mice, Inbred C57BL; Myocarditis; Simvastatin; Thrombosis; Tirofiban; Tyrosine | 2011 |
Tirofiban versus abciximab: tirofiban is administered at suboptimal dosages when evaluated in an arterial thrombosis model in non-human primates.
Topics: Abciximab; Animals; Antibodies, Monoclonal; Anticoagulants; Disease Models, Animal; Immunoglobulin Fab Fragments; Primates; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine | 2012 |
Acute myocardial infarction during the early postpartum period successfully treated with tirofiban.
Topics: Acute Disease; Adult; Coronary Angiography; Electrocardiography; Heart Valve Prosthesis; Humans; Male; Mitral Valve Insufficiency; Myocardial Infarction; Platelet Aggregation Inhibitors; Postpartum Period; Thrombosis; Tirofiban; Tyrosine | 2012 |
Huge left atrial appendage thrombus in a patient with atrial fibrillation: successful treatment with tirofiban.
Topics: Aged; Atrial Appendage; Atrial Fibrillation; Female; Humans; Platelet Aggregation Inhibitors; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine | 2013 |
Impact of preprocedural TIMI flow on myocardial perfusion, distal embolization and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb/IIIa inhibitors.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Electrocardiography; Eptifibatide; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Incidence; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Regional Blood Flow; Regression Analysis; Retrospective Studies; Risk Factors; Survival Rate; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine | 2012 |
Percutaneous femoral artery angioplasty with stent-in-stent technique and tirofiban administration.
Topics: Angioplasty, Balloon; Female; Femoral Artery; Fibrinolytic Agents; Humans; Middle Aged; Recurrence; Stents; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine | 2002 |
Effects of GP IIb/IIIa receptor inhibitor tirofiban (aggrastat) in ex vivo canine arteriovenous shunt model of stent thrombosis.
Topics: Animals; Arteriovenous Shunt, Surgical; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrinolytic Agents; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine | 2003 |
Glycoprotein IIb/IIIa inhibitors and no-reflow.
Topics: Animals; Coronary Circulation; Fibrinolytic Agents; Humans; Microcirculation; Models, Animal; Myocardial Infarction; Myocardial Reperfusion; Platelet Glycoprotein GPIIb-IIIa Complex; Reperfusion Injury; Thrombosis; Tirofiban; Tyrosine; Vascular Patency | 2004 |
Ability of anti-glycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions.
Topics: Abciximab; Adult; Antibodies, Monoclonal; Anticoagulants; Arginine; Blood Platelets; Collagen; Eptifibatide; Fibrinolytic Agents; Hemorheology; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Peptides; Pipecolic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides; Thrombosis; Tirofiban; Tyrosine | 2004 |
Continuous tenecteplase infusion combined with peri/postprocedural platelet glycoprotein IIb/IIIa inhibition in peripheral arterial thrombolysis: initial safety and feasibility experience.
Topics: Aged; Drug Therapy, Combination; Feasibility Studies; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Infusions, Intravenous; Ischemia; Leg; Male; Middle Aged; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Tenecteplase; Thrombolytic Therapy; Thrombosis; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine | 2004 |
Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Blood Vessel Prosthesis; Death, Sudden, Cardiac; Emergency Treatment; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Platelet Aggregation Inhibitors; Secondary Prevention; Stents; Survival Analysis; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine | 2005 |
The effect of tirofiban on microvascular thrombosis: crush model.
Topics: Anastomosis, Surgical; Animals; Disease Models, Animal; Femoral Artery; Isotonic Solutions; Microsurgery; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Random Allocation; Rats; Rats, Sprague-Dawley; Ringer's Lactate; Thrombosis; Tirofiban; Tyrosine; Vascular Patency | 2005 |
Delayed stenting of a thrombotic saphenous vein graft after intravenous tirofiban pretreatment.
Topics: Aged; Coronary Disease; Humans; Male; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Saphenous Vein; Stents; Thrombosis; Tirofiban; Tyrosine | 2006 |
Iliac artery thrombosis after aortic balloon counterpulsation: treatment with intraarterial tirofiban, manual thrombectomy and stenting.
Topics: Aged; Coronary Angiography; Fibrinolytic Agents; Heparin; Humans; Iliac Artery; Infusions, Intra-Arterial; Intra-Aortic Balloon Pumping; Male; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombectomy; Thrombosis; Tirofiban; Tyrosine | 2006 |
Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling.
Topics: Adenosine Monophosphate; Blood Platelets; Calcium Channel Blockers; Calcium Signaling; Collagen; Humans; In Vitro Techniques; Lanthanum; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Thrombosis; Tirofiban; Tyrosine | 2006 |
Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.
Topics: Amino Acid Motifs; Animals; Antibodies; Bleeding Time; Blood Platelets; Carotid Artery Diseases; Chlorides; Complementarity Determining Regions; Eptifibatide; Ferric Compounds; Fibrinogen; Fibrinolytic Agents; Humans; Mice; Mice, Inbred C57BL; Molecular Conformation; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine | 2006 |
Mitigation of device-associated thrombosis and thromboembolism using combinations of heparin and tirofiban.
Topics: Animals; Anticoagulants; Drug Therapy, Combination; Heparin; In Vitro Techniques; Male; Platelet Aggregation Inhibitors; Sheep; Stents; Thromboembolism; Thrombosis; Tirofiban; Tyrosine | 2006 |
Prevention of microsurgical anastomotic thrombosis using aspirin, heparin, and the glycoprotein IIb/IIIa inhibitor tirofiban.
Topics: Anastomosis, Surgical; Animals; Anticoagulants; Aspirin; Drug Therapy, Combination; Heparin; Male; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Random Allocation; Rats; Rats, Sprague-Dawley; Thrombosis; Tirofiban; Tyrosine; Vascular Patency | 2007 |
Reduced fibrin deposition and intravascular thrombosis in hDAF transgenic pig hearts perfused with tirofiban.
Topics: Adult; Animals; Animals, Genetically Modified; Antibodies; CD55 Antigens; Complement C3; Complement C4; Creatine Kinase; Disaccharides; Fibrin; Fibrinolytic Agents; Heart; Heart Transplantation; Humans; Male; Myocardium; Swine; Thrombosis; Tirofiban; Transplantation, Heterologous; Tyrosine | 2007 |
Rescue use of tirofiban for acute carotid in-stent thrombosis.
Topics: Acute-Phase Reaction; Angiography; Carotid Artery Diseases; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Stents; Thrombosis; Tirofiban; Tyrosine | 2008 |
Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasis.
Topics: Animals; Anticoagulants; Arginine; Arteriovenous Shunt, Surgical; Aspirin; Bleeding Time; Chlorides; Ferric Compounds; Guinea Pigs; Hemostasis; Male; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombosis; Tirofiban; Tyrosine | 2008 |
Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.
Topics: Adenosine Diphosphate; Animals; Coronary Circulation; Dogs; Female; Hemostasis; In Vitro Techniques; Male; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Streptokinase; Thrombosis; Tirofiban; Tissue Plasminogen Activator; Tyrosine | 1995 |
Glycoprotein IIb/IIIa receptor antagonist tirofiban inhibits thrombin generation during cardiopulmonary bypass in baboons.
Topics: Animals; Cardiopulmonary Bypass; Fibrinolytic Agents; Intraoperative Complications; Papio; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombin; Thrombosis; Tirofiban; Tyrosine | 1999 |
Abciximab, eptifibatide, and tirofiban: comparison of parenteral glycoprotein IIb/IIIa inhibitors.
Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Clinical Trials as Topic; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Infusions, Parenteral; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine | 1999 |
Ultrasound has synergistic effects in vitro with tirofiban and heparin for thrombus dissolution.
Topics: Albumins; Blood Coagulation; Contrast Media; Fibrin; Fibrinolytic Agents; Fluorocarbons; Heparin; Humans; In Vitro Techniques; Sodium Chloride; Solubility; Sonication; Stents; Thrombosis; Time Factors; Tirofiban; Tissue Plasminogen Activator; Tyrosine | 1999 |
Diffuse alveolar hemorrhage following administration of tirofiban or abciximab: a nemesis of platelet glycoprotein IIb/IIIa inhibitors.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Fatal Outcome; Female; Hemoptysis; Humans; Immunoglobulin Fab Fragments; Male; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pulmonary Alveoli; Thrombosis; Tirofiban; Tyrosine | 2000 |
An in-vitro model to study device-induced thrombosis and embolism: evaluation of the efficacy of tirofiban, aspirin, and dipyridamole.
Topics: Animals; Anticoagulants; Aspirin; Blood Flow Velocity; Cattle; Dipyridamole; Dose-Response Relationship, Drug; Edetic Acid; Embolism; Equipment and Supplies; Equipment Design; Evaluation Studies as Topic; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Scattering, Radiation; Stents; Thrombosis; Tirofiban; Tyrosine | 2000 |
The role of tirofiban in acute coronary syndromes.
Topics: Angina, Unstable; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis; Tirofiban; Tyrosine | 2000 |
[Different inhibiting effects of abciximab and tirofiban on platelet thrombus formation on a collagen surface under flow conditions].
Topics: Abciximab; Adult; Antibodies, Monoclonal; Anticoagulants; Collagen; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Microscopy, Fluorescence; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine | 2000 |
[Lysis of an extensive thrombus in the internal carotid artery using a glycoprotein IIb/IIIa receptor antagonist].
Topics: Aphasia, Broca; Carotid Artery, Internal; Carotid Stenosis; Cerebral Angiography; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Male; Middle Aged; Paralysis; Platelet Glycoprotein GPIIb-IIIa Complex; Smoking; Thrombosis; Tirofiban; Tomography, X-Ray Computed; Tyrosine | 2001 |
Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein IIb/IIIa inhibitor: report of four cases.
Topics: Aged; Basilar Artery; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tissue Plasminogen Activator; Tyrosine | 2001 |
Platelet inhibition after glycoprotein IIb/IIIa inhibitor therapy.
Topics: Abciximab; Antibodies, Monoclonal; Blood Platelets; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Tirofiban; Tyrosine | 2001 |
Comparative antithrombotic effects of magnesium sulfate and the platelet glycoprotein IIb/IIIa inhibitors tirofiban and eptifibatide in a canine model of stent thrombosis.
Topics: Animals; Arteriovenous Shunt, Surgical; Bleeding Time; Blood Coagulation; Blood Pressure; Dogs; Eptifibatide; Fibrinolytic Agents; Heart Rate; Heparin; Magnesium Sulfate; P-Selectin; Peptides; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombosis; Time Factors; Tirofiban; Tyrosine | 2002 |